Allergy Therapeutics
AGY.L
#7054
Rank
ยฃ0.33 B
Marketcap
ยฃ0.07000
Share price
1.45%
Change (1 day)
198.72%
Change (1 year)

Revenue for Allergy Therapeutics (AGY.L)

Revenue in 2024: ยฃ55.19 Million

According to Allergy Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ54 Million. In 2024 the company made a revenue of ยฃ55.19 Million a decrease over the revenue in the year 2023 that were of ยฃ59.58 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Allergy Therapeutics from 2002 to 2024

Annual revenue

Year Revenue Change
2024ยฃ55.19 M-7.36%
2023ยฃ59.58 M-18.11%
2022ยฃ72.76 M-13.71%
2021ยฃ84.33 M7.83%
2020ยฃ78.2 M6.09%
2019ยฃ73.71 M7.86%
2018ยฃ68.34 M6.56%
2017ยฃ64.13 M32.22%
2016ยฃ48.5 M12.21%
2015ยฃ43.23 M3.04%
2014ยฃ41.95 M6.81%
2013ยฃ39.27 M-4.85%
2012ยฃ41.28 M-0.65%
2011ยฃ41.55 M1.97%
2010ยฃ40.75 M7.93%
2009ยฃ37.75 M21.71%
2008ยฃ31.02 M20.51%
2007ยฃ25.74 M9.27%
2006ยฃ23.55 M14.33%
2005ยฃ20.6 M14.47%
2004ยฃ18 M3.88%
2003ยฃ17.32 M14.47%
2002ยฃ15.13 M